Presence and Risk Factors for Glaucoma in Patients with Diabetes. - Wikidata - wikimedia - TriplyDB

Presence and Risk Factors for Glaucoma in Patients with Diabetes.

Presence and Risk Factors for Glaucoma in Patients with Diabetes.

http://www.wikidata.org/entity/Q30244246

about

Triglycerides and Open Angle Glaucoma - A Meta-analysis with meta-regression.Awareness and practices regarding eye diseases among patients with diabetes: a cross sectional analysis of the CoDiab-VD cohort.Sustained intraocular pressure elevation in eyes treated with intravitreal injections of anti-vascular endothelial growth factor for diabetic macular edema in a real-life setting.Progression of Primary Open Angle Glaucoma in Diabetic and Non-diabetic Patients.No evidence of a causal relationship between hypothyroidism and glaucoma: A Danish nationwide register-based cohort study.Clinical study on primary open-angle glaucoma with Ashchyotana, Tarpana and oral medication.Insulin signalling promotes dendrite and synapse regeneration and restores circuit function after axonal injury.Structural and Functional Rescue of Chronic Metabolically Stressed Optic Nerves through Respiration

P2860

Q41354254-97B9BCB0-6506-4273-B7E3-430DF9D3B6BE Q41524790-1A89E880-B7C2-4912-A15E-C16DF1A0DF26 Q47918653-48FBA7FE-BEB5-40FC-92AB-C6CE54B6A196 Q49971181-AF2F3EC7-86D1-42E1-9719-7CC271016536 Q50000555-D34BDCCE-C199-4285-8619-32FBADDEC99F Q55358678-0C87A113-1FA2-4009-9600-760C87FC26C7 Q55514148-82E13601-6036-4BFE-A736-DF7C90227AB2 Q56936883-BC4201BB-7B86-47B7-930E-44593FB62C55

P2860

Presence and Risk Factors for Glaucoma in Patients with Diabetes.

http://www.wikidata.org/entity/Q30244246

description

2016 nî lūn-bûn

@nan

2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Presence and Risk Factors for Glaucoma in Patients with Diabetes.

@ast

Presence and Risk Factors for Glaucoma in Patients with Diabetes.

@en

type

label

Presence and Risk Factors for Glaucoma in Patients with Diabetes.

@ast

Presence and Risk Factors for Glaucoma in Patients with Diabetes.

@en

prefLabel

Presence and Risk Factors for Glaucoma in Patients with Diabetes.

@ast

Presence and Risk Factors for Glaucoma in Patients with Diabetes.

@en

P1433

Q30244246-CFA86BC9-0B9B-4D57-B089-BEBB4EC71C1E

P1476

Q30244246-51BF8E76-F89B-4119-9B1C-B531AC95172E

P2093

Q30244246-099819F4-9448-4FCF-81D8-B39EDD538E2D

Q30244246-74044FBF-52F9-4998-A7A7-84C345F3C4B9

Q30244246-B7C14508-2AC4-44A8-A81D-706E59206C91

P2860

Q30244246-016DC2B1-0E3E-4CB6-AEAD-EEA314B0ACAD

Q30244246-0B1DFE75-D7C6-43FF-9B18-DC6F6DA0E00C

Q30244246-0D609556-E895-4C3B-9191-264F60962C38

Q30244246-0DB4AB65-8936-4CE9-BBCF-A95FE54C925E

Q30244246-0DFBDF54-C870-4B97-8555-28E551FD5773

Q30244246-10812BEA-3989-43A4-8FD7-1EAE50B8FAB6

Q30244246-1222FD5F-9E46-45A1-BA3E-0FABD07FE0BE

Q30244246-1315F6C1-59C9-429B-A34D-B0014CA0DB45

Q30244246-13FC64B4-BF34-4175-B476-BA469CD2A27D

Q30244246-14E9C74C-176F-410A-AF69-89989E77ACAD

P2888

Q30244246-5661C1A8-C642-4707-96F6-75344F71BB09

P304

Q30244246-C74EE2C7-DB9C-4148-850A-6F8F265BB3BD

P31

Q30244246-21363F4A-75EE-47B8-99EA-AA656920EFE7

P356

Q30244246-35E50229-905C-40A0-A2CD-E75EEE254EB0

P433

Q30244246-BF5C2ABA-6089-468B-9B9C-25AB109749E4

P478

Q30244246-7E631FF0-A08D-4162-B2EF-C154FB2447C7

P577

Q30244246-70B90DED-0B34-4D76-A376-333B9AE0734B

P6179

Q30244246-F9A15736-1A0B-4583-9221-B4BEAC851FB2

P698

Q30244246-AD99B361-3095-45D3-BCA4-078A246DE814

P932

Q30244246-C86B5E9E-2336-416C-A033-BE5B760CF2ED

P356

S11892-016-0815-6

P1433

Current diabetes report

P1476

Presence and Risk Factors for Glaucoma in Patients with Diabetes.

@en

P2093

Brian J Song

http://www.w3.org/2001/XMLSchema#string

Lloyd Paul Aiello

http://www.w3.org/2001/XMLSchema#string

Louis R Pasquale

http://www.w3.org/2001/XMLSchema#string

P2860

Nitric oxide and peroxynitrite in health and disease

The number of people with glaucoma worldwide in 2010 and 2020

Diabetes Dyslipidemia

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin

Adult-onset primary open-angle glaucoma caused by mutations in optineurin

S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding

The role of the amadori product in the complications of diabetes

Dyslipidemia and eye diseases in the adult Chinese population: the Beijing eye study

Global estimates of the prevalence of diabetes for 2010 and 2030

P2888

s11892-016-0815-6

P304

124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11892-016-0815-6

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1026116413

http://www.w3.org/2001/XMLSchema#string

P698

27766584

http://www.w3.org/2001/XMLSchema#string

P932

5310929

http://www.w3.org/2001/XMLSchema#string